Introduction Methods
Platelet activating factor (PAF) has been implicated in the pathogenesis of bronchial asthma as PAF has a number of biological properties of relevance to this disease (Page, 1988) . PAF is of particular interest as it is able to induce a longlasting and non-specific bronchial hyperresponsiveness both in experimental animals (Mazzoni et al., 1985; Chung et al., 1986; Barnes et al., 1987; Robertson et al., 1988) and man (Cuss et al., 1986) . However, the precise mechanisms underlying this heightened airway responsiveness are unknown. It has been suggested that bronchial hyperresponsiveness is secondary to airway inflammation as a number of stimuli capable of inducing bronchial hyperresponsiveness also induce an infiltration of inflammatory cells, principally neutrophils and eosinophils into the airways (Chung et al., 1985; Murphy et al., 1986) . Moreover, depletion of circulating leucocytes has been demonstrated to inhibit the development of bronchial hyperresponsiveness in experimental animals (O'Byrne et al., 1984; Marsh et al., 1985) , but this has not been observed by other investigators (Murlas & Roum, 1985; Thompson et al., 1986; Cibulas et al., 1988) . Other investigators have also suggested that alterations in airway smooth muscle function (Antonnissen et al., 1979) , bronchial wall oedema (Persson, 1986) or geometric factors (James et al., 1989 ) may contribute to bronchial hyperresponsiveness. It is now recognized that some of the biological activities of PAF are secondary to platelet activation (Vargaftig et al., 1980; Mazzoni et al., 1985; Lellouch-Tubiana et al., 1988) and that the platelet may act as an inflammatory cell in its own right (Page, 1989 ).
The present study has therefore attempted to investigate whether PAF-induced bronchial hyperresponsiveness is secondary to changes in airway smooth muscle function or platelet activation.
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In vivo experiments
New Zealand White rabbits (3-3.5 kg) were anaesthetized with diazepam (5mg ml-', 5mg kg-' i.p.) and fentanyl citrate (0.315mgml-', 0.4mlkg-I i.m.) and placed in a supine position. Rabbits were intubated with a 3.0mm endotracheal tube which was connected to a pneumotachograph (Bore 00) and the flow determined by a Validyne pressure transducer. Pleural pressure was estimated by placing an oesophageal balloon in the lower third of the oesphagus to obtain the maximum expiratory pressure. Thoracic pressure was measured by a sidehole catheter on the distal end of the tracheal tube. Transpulmonary pressure, the difference between thoracic and pleural pressure was measured with a differential pressure transducer (Validyne). The flow was integrated to obtain a continuous recording of tidal volume. Measurements of total lung resistance (Rd and dynamic compliance (Cdyn) were calculated by a pulmonary mechanical analyser (Buxco, Model 6, Sharon, CT, U.S.A.) as described previously (Giles et al., 1974) . Anaesthesia was maintained throughout the course of the experiment by administration of 0.2-0.3 ml fentanyl citrate intramuscularly every 30-40min, according to the protocol described by Flecknall (1987) .
Assessment ofairway responsiveness to histamine Airway responsiveness to histamine was determined by exposing rabbits to increasing concentrations of histamine (1.2% 80mgmlP') administered to the lungs directly via an endotracheal tube. Aerosols were generated by a Devilbiss ultrasonic nebuliser which has previously been demonstrated to generate particles of which 80% are less than 0.5,am in diameter.
After measurement of baseline lung function, animals were exposed to an aerosol of sterile saline for 2min immediately followed by lung function measurements. Increasing concentrations of histamine were administered, with each dose being given for 2 min, until there was at least a doubling in RL or a 30% fall in CdY,. The provocation dose (PD) of histamine which produced a 100% increase in RL (PD100) and 30% fall in Cdyfl (PD30) was determined for each animal and used as an index of airway responsiveness.
On day 2 animals were re-anaesthetized and a PAF challenge performed. After exposure to an aerosol of 0.25% bovine serum albumin (BSA) for 2 min, rabbits were exposed to PAF (80,ugml-1) administered over a 1 h period. Lung function was then monitored for a 1 h period after exposure to PAF. Control animals received an aerosol of BSA followed by exposure to an aerosol of BSA containing the same concentration of ethanol as that received by the PAF-treated animals (approx. 1%).
On day 3, increasing concentrations of histamine were administered to the anaesthetized rabbits as on day 1 and the PD100 for histamine determined.
Bronchoalveolar lavage
On completion of the concentration-effect curve to histamine on day 1 and day 3, a bronchoalveolar lavage (BAL) was performed. Rabbits were lavaged by passing a cannula into the airways via the endotracheal tube until it was wedged. Three millilitres of 10% normal rabbit serum in 0.9% sterile saline was injected and immediately aspirated from the lungs. Total cell counts were determined under light microscopy by an improved Neubauer haemocytometer. Cytospins were prepared, fixed and stained with Lendrum's stain. A total of 200 cells were counted differentially and classified as neutrophils, eosinophils or mononuclear cells based on standard morphological criteria. The return volume of BAL was 1.97 + 0.13 ml (n = 15) and had a coefficient of variation of 26%.
Preparation of anti-platelet serum
Guinea-pig anti-rabbit platelet serum (APS) was a kind gift of Dr K.D. Butler (Ciba-Geigy Pharmaceuticals, Horsham, U.K.), prepared according to the protocol described by Butler & Smith (1982 .6%, n = 5, P < 0.05, Figure 2 ).
Effect of PAF on airway responsiveness to histamine
Resistance The concentration of histamine required to increase RL by 100% (PD100) was 47.1 mgml-' (42.0-52.8; n = 10). A significant increase in airway responsiveness to histamine was observed 6 h (12.0 mg ml-1 (9.5-15.1), P < 0.05; n = 4) and 24h (19.Omgml-1 (14.4-25.1), P < 0.05; n = 5) but not 72h (52.5 mgml-1 (44.2-62.4), P > 0.05; n = 4) following exposure to an aerosol of PAF. Airway responsiveness to histamine was not significantly different 6 h (33.1 mg ml-1 (25.9-42.4), P > 0.05; n = 2), 24 h (44.7mgmlP1 (38.5-51.8), P > 0.05; n = 5) and 72h (61.4mgmlP1 (45.5-82.8), P > 0.05; n = 4) following exposure to an aerosol of BSA. The mean results shown in Figure 3a were obtained after logarithmic transformation of the data.
Compliance The concentration of histamine required to decrease CdY. by 30% (PD30) was 60.7mgml-' (55.3-66.0; n = 10). A significant increase in airway responsiveness to histamine was observed 6h (20.4mgml-1 (12.0-34.7), P < 0.05; n = 5) and 24h (23.4mgml-' (18.2-30 .2), P < 0.05; n = 5) but not 72h (74.1 mgml-' (61.6-100.0), P > 0.05; n = 4) following exposure to an aerosol of PAF. Figure 3b were obtained after logarithmic transformation of the data. Effect of administration of anti-platelet or normal serum on circulating platelet and white blood cell count Administration of either anti-platelet serum (APS) or normal guinea-pig serum (NGPS) failed to alter the total number of circulating leucocytes compared with untreated animals (Table 1) . A significant increase in the number of neutrophils and a decrease in the number of mononuclear cells following administration of APS compared with control animals was observed. However, administration of the NGPS induced a similar neutrophilia and reduction in the number of mononuclear cells which was not significantly different from that induced by APS (Table 1) .
Effect ofplatelet depletion on histamine-induced bronchoconstriction
The RL PD100 following histamine administration was 50.1 mg ml-1 (42.7-58.9; n = 5). Administration of APS failed to modify histamine-induced bronchoconstriction (PD0oo 44.7 mgmml (33.9-58.9), n = 5; P > 0.05).
Effect ofplatelet depletion on PAF-induced bronchial hyperresponsiveness
In another series of experiments, an increase in airways responsiveness to histamine was observed 24 h following exposure to PAF in naive (pretreatment PD100: 51.3 mg ml-1 (43.2-60.8); 24h post-treatment: PD100 30.2 mgml-1 (24.0-38.0), n = 9, P < 0.05, Figure 4a ) and NGPS-treated rabbits (pretreatment: 58.9 mgmlP (47.0-73.8); (post-treatment: 28.8 mgmi-1 (21.9-38.0), n = 6, P < 0.05, Figure 4a ). NGPS treatment alone failed to alter the PAF-induced increase in airway responsiveness to histamine (P < 0.05). PAF increased airway responsiveness to histamine by 2 fold or greater in 5 rabbits, by 1.4 fold in 7 rabbits and minimally in 3 rabbits (Figure 4a ). In contrast, airway responsiveness to histamine was not increased 24 h following exposure to BSA in NGPStreated rabbits (pretreatment: 45.3 mgml-1 (32.2-63.7): posttreatment: 43.2mgmlP1 (32.1-58.2), n = 5, P > 0.05, Figure   4b ). In animals rendered thrombocytopenic, PAF failed to increase airway responsiveness to histamine (pretreatment: 56.Omgml-l (43.6-72.4); post-treatment: 54.2mgmlP1 (38.4-76.6), n = 5, P > 0.05, Figure 4c ). The individual data for the 3 groups of rabbits are shown in Figure 4 .
Bronchoalveolar lavage
Before PAF exposure, mononuclear cells comprised greater than 95% of the resident cell population with a small (generally less than 5%) number of neutrophils. The mean pretreatment cell counts from the 3 groups were not significantly different (P > 0.05, ANOVA) and consequently the pretreatment cell counts from each group were pooled, as presented in Table 2 . PAF induced a significant increase in the total number of leucocytes in the airways as assessed by BAL, 24 h after PAF exposure in animals treated with NGPS (ANCOVA F(2,1 1) = 6.2, P < 0.01; Table 2 ). Although there was an increase in the numbers of neutrophils and monocytes in BAL following PAF this was not significant (P > 0.05, ANCOVA). In contrast, a small but significant increase in the numbers of BAL eosinophils following PAF was observed (P < 0.05). Exposure to an aerosol of BSA in rabbits treated with NGPS induced a small but insignificant increase in the total cell infiltrate (Table 2 ). However, there was a significant increase in the number of neutrophils in the airways after BSA (P < 0.05, paired t test). BSA treatment induced no significant changes in the number of eosinophils or mononuclear cells. Depletion of circulating platelets reduced the PAF-induced leucocyte infiltration (P < 0.05) and this was associated with a reduction in the number of eosinophils (Table 2 ).
In vitro studies
Contractile agonists Carbachol, methacholine and histamine produced concentration-dependent contractions in bronchial n (number below each result) = number of animals and n (number in parentheses) indicates the total number of bronchial preparations. * Relaxant potency for theophylline significantly reduced in rabbits exposed to PAF compared with BSA (P < 0.01, non-paired t test). Results are expressed as mean + s.e.mean. n = similar to those given in Table 2. preparations from rabbits exposed to BSA or PAF. However, there was no significant difference in either the contractile potency (pD2) or maximal tension generated (mgmg-1 wet weight) for carbachol, methacholine and histamine in bronchi from rabbits exposed to BSA or PAF (P > 0.05; Tables 3 and  4) . PAF (0.001-1 pM) itself failed to contract isolated bronchi from naive rabbits (n = 3 rabbits providing 18 bronchial preparations).
Relaxant agonists Isoprenaline and theophylline produced concentration-dependent relaxation of carbachol-induced tone in bronchial preparations from both 0.25% BSA-treated and PAF-treated rabbits. The maximal relaxant response was 70 + 11% (n = 5) and 78 + 22% (n = 4) in rabbits exposed to BSA and PAF, respectively. Similarly, for theophylline the maximal relaxant response was 154 + 19% (n = 5) and 147 + 12% (n = 5) in rabbits exposed to BSA and PAF, respectively. The relaxant potency of isoprenaline was not significantly different in bronchial preparations from rabbits exposed to BSA compared with PAF (P > 0.05, Table 3 ). In contrast the relaxant potency to theophylline was reduced by 2.58 fold in bronchial preparations from rabbits exposed to PAF compared with those from rabbits exposed to BSA (Table 3) .
Discussion
It is becoming increasingly apparent that PAF may play a significant role in the pathogenesis of asthma, as it mimics many of the features which are characteristic of asthma Page, 1988) . We have therefore investigated the ability of PAF to induce airway hyperresponsiveness and inflammation in the rabbit and assessed the relative contribution of the platelet and airway smooth muscle function to these responses. Exposure of rabbits to an aerosol of PAF induced acute bronchoconstriction. PAF has previously been shown to induce a platelet-dependent bronchoconstriction in this and other species following intravenous administration (Vargaftig et al., 1980; Halonen et al., 1985) . Similarly in our experiments, aerosol administration of PAF induced a plateletdependent bronchoconstriction. Furthermore, isolated bronchial preparations failed to contract to PAF under conditions where they readily contracted to other spasmogens. Our in vitro results are consistent with the inability of PAF to contract canine trachea (Popovich et al., 1988) , guinea-pig trachea (Cerrina et al., 1983) and human bronchus (Schellenberg et al., 1983) unless platelets are present (Schellenberg et al., 1983; Popovich et al., 1988) . However, our results are in contrast to those of Lefort et al. (1984) , who demonstrated that whilst bronchoconstriction induced by systemically administered PAF was platelet-dependent in the guinea-pig, an aerosol of PAF induced a platelet-independent bronchoconstriction.
No change in the number of circulating platelets or leucocytes was observed following aerosol exposure to PAF. This is consistent with studies performed in the guinea-pig (Lefort et al., 1984) . However, a change in a minority cell population may still have occurred which we did not detect as we did not perform differential leucocyte counts on peripheral blood samples. In man, a transient neutropenia without thrombocytopenia was observed following inhalation of PAF (Roberts et al., 1988) . The lack of an effect on circulating platelets in man and rabbit suggests that platelet aggregation per se is not necessary for PAF-induced effects in the lung, consistent with observations made in other species .
Following exposure to PAF, airway responsiveness to histamine was increased at 6-24 h later. Such effects are consistent with those obtained following systemic administration or inhalation of PAF in the dog (Chung et al., 1986) , guinea-pig (Mazzoni et al., 1985; Barnes et al., 1987; Coyle et al., 1988a; Robertson et al., 1988) , rabbit (Nieminen et al., 1988) and in man (Cuss et al., 1986) . In our study the ability of PAF to induce airway hyperresponsiveness to histamine was relatively small (approx 1.5-4 fold) and did not occur in all animals. This observation is of interest for it has rescently been found that PAF will not induce bronchial hyperresponsiveness in all subjects (Jenkins et al., 1989) and in the rabbit at least, is susceptible to changes in body temperature (Nieminen et al., 1989) . The underlying mechanisms whereby PAF can induce an increase in airway responsiveness is unclear. However, platelet activation appears to be important, as platelet depletion with a selective anti-serum inhibited PAF-induced airway hyperresponsiveness. Our results confirm previous observations in the guinea-pig that PAF induces a platelet-dependent increase in airway responsiveness (Mazzoni et al., 1985) .
Studies performed in both experimental animals and man suggest airway inflammation is important in heightened airway responsiveness (Chung, 1987) . In the present study, PAF induced a 4 fold increase in the number of leucocytes in the airways as assessed by BAL and our results are consistent with previous in vivo findings that PAF can elicit airway inflammation (Camussi et al., 1983; Lellouch-Tubiana et al., 1988; Coyle et al., 1988a) . The differential cell counts revealed a trend towards an increase in the number of neutrophils and mononuclear cells which, due to the variability in the magnitude of the change between animals, did not reach statistical significance. However, there was a significant increase in the number of eosinophils in BAL fluid obtained from rabbits 24h after exposure to PAF, which was small when compared with the increase in the numbers of neutrophils and mononuclear cells. Exposure to BSA also produced an increase in the number of neutrophils, probably as a result of non-specific inflammation.
PAF has been demonstrated to be a potent activation stimulus for neutrophils (Kurihara et al., 1989) , niononuclear cells (Yasaka et al., 1982) and eosinophils (Wardlaw et al., 1986; Tamura et al., 1987) . Furthermore, specific binding sites for PAF have recently been indentified on the surface of these cell types (Kurihara et al., 1989) . PAF has also been demonstrated to induce neutrophil and mononuclear cell accumulation in vivo following intracutaneous adminstration in healthy individuals (Archer et al., 1985) , whereas local administration of PAF to the skin of allergic subjects induces predominantly an eosinophil-rich infiltrate (Henocq & Vargaftig, 1986) . Aerosol administration of PAF in man induces a transient neutropenia which probably reflects sequestration of neutrophils in the pulmonary vasculature (Roberts et al., 1988) . PAF exposure also induced an increase in the number of mononuclear cells in the BAL 24h after challenge and these observations are consistent with those observed following intratracheal administration of PAF in the rabbit (Camussi etal., 1983) .
In these experiments, the ability of PAF to induce leucocyte infiltration into the airways was dependent on platelet activation, since the total number of inflammatory cells found in lavage fluid after exposure to PAF was significantly reduced in thrombocytopenic animals. The differential cell counts only revealed significance for the effect of APS on PAF-induced eosinophil infiltration, although there was a tendency for the number of neutrophils and mononuclear cells to fall as well. The precise mechanisms underlying platelet-dependent cellular infiltration are unknown, but our results are consistent with a platelet-dependent eosinophilia observed in the rabbit following exposure to allergen (Coyle et al., 1988b) and in guinea-pig following exposure to PAF or allergen (LellouchTubiana et al., 1988) . However, recent studies in the guineapig have not found any significant effect of platelet depletion on eosinophil infiltration in the lung induced by an aerosol of PAF (Sanjar et al., 1990) . Nevertheless, it is recognized that platelets can release a variety of chemotactic factors for neutrophils (e.g. platelet factor 4 (PF4), platelet derived growth factor (PDGF) and certain lipoxygenase metabolites of arachidonic acid), eosinophils (PF4) and mononuclear cells (e.g. PF4, transforming growth factor-beta (TGF-IJ)) (Page, 1989) .
Our results are of interest because platelet activation has recently been suggested to occur chiefly in allergic asthmatics, and increased platelet turnover (Gresele et al., 1987) , reduced platelet survival time (Taytard et al., 1986) and prolonged bleeding times (Szczeklik et al., 1986 ) have all been found to be features of allergic asthma. However, such changes have not been observed consistently within the allergic population (Hemmendinger et al., 1989) . Nevertheless, platelet aggregates have recently been found in the lung vasculature (Beasley et al., 1989) , platelets have been observed on damaged airway epithelium in symptomatic asthmatics (Jeffery et al., 1989) and in BAL fluid obtained from allergic asthmatics (Metzger et al., 1986) following allergen challenge. Furthermore, the exerciseinduced rise in plasma levels of PF4 and /J-thromboglobulin were attenuated in asthmatics following treatment with the PAF-antagonist BN 52036 (Wilkens et al., 1990) .
We have also investigated whether altered smooth muscle function could account for the bronchial hyperresponsiveness observed in vitro. The contractile potency to histamine, carbachol and methacholine was not enhanced in rabbits exposed to PAF compared with rabbits exposed to BSA. Similarly, the maximum tension developed in response to these spasmogens was similar in bronchi taken from both sources. These results are consistent with those found in guinea-pigs exposed to PAF (Robertson et al., 1988) and suggest that alterations in airway smooth muscle function per se are not responsible for PAF-induced bronchial hyperresponsiveness. Similarly, no alteration in airway smooth muscle function has been observed in bronchi taken from asthmatic lung (Cerrina et al., 1986; Goldie et al., 1986) except in isolated cases (Schellenberg & Foster, 1984; De Jongste et al., 1987) .
We also assessed whether PAF-induced bronchial hyperresponsiveness was associated with a loss in airway /-adrenoceptor function. There was no alteration in the relaxant potency to isoprenaline in bronchi from rabbits exposed to PAF compared with BSA-treated rabbits, consistent with previous findings in other species . However, other investigators have demonstrated that incubation of lung membranes with PAF did result in a reduction in /1-adrenoceptor density , an effect presumably due to the high concentrations of PAF utilised in vitro. Furthermore, our observations in the rabbit are consistent with those obtained in mild asthma where no alteration in f-adrenoceptor function has been observed (Svedymyr et al., 1977) . However, in severe asthma, fl-adrenoceptor dysfunction has been demonstrated (Cerrina et al., 1986; Goldie et al., 1986) . In contrast, the potency of theophylline was reduced in bronchi taken from rabbits previously exposed to PAF. The reasons for this remain unclear but may involve a cyclic AMP-independent mechanism, since fl-adrenoceptor function was unaltered.
PAF has recently been shown to be a potent substrate at inducing vascular permeability in the airways (Evans et al., 1987) and airway oedema has been suggested to contribute to airway hyperresponsiveness (Persson, 1986) . However, recent investigations in the guinea-pig have suggested no causal relationship between airway vascular permeability and bron-chial hyperresponsiveness (Roberts & Barnes, 1989) . Chronic administration of PAF has also been shown to induce changes in smooth muscle thickening (Touvay et al., 1990) and airway connective tissue (Schellenberg, 1987) which may occur via a different mechanism from that described in the present study. The contribution of platelets and airways inflammation to those long-term anatomical changes remains unknown.
In summary, we have demonstrated that PAF induces both bronchial hyperresponsiveness and airway inflammation which are dependent on some aspect of platelet activation. However, this increase in airway responsiveness is not a consequence of changes in airway smooth muscle function per se.
